The combination of Biochanin A and SB590885 potentiates the inhibition of tumour progression in hepatocellular carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) is the most aggressive and frequently diagnosed malignancy of the liver. Despite aggressive therapy, life expectancy of many patients in these cases is extended by only a few months. Hepatocellular carcinoma (HCC) has a particularly poor prognosis and would...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Yi, Gong, Qiang, Wang, Wenhong, Liu, Fang, Kong, Qinghong, Pan, Feng, Zhang, Xiaoke, Yu, Changyan, Hu, Shanshan, Fan, Fang, Li, Sanhua, Liu, Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7405455/
https://www.ncbi.nlm.nih.gov/pubmed/32774165
http://dx.doi.org/10.1186/s12935-020-01463-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7405455/
https://www.ncbi.nlm.nih.gov/pubmed/32774165
http://dx.doi.org/10.1186/s12935-020-01463-w

Ejemplares similares